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This report outlines the main conclusions from an 
expert consultation on molecular epidemiology held 
on 22–23 November 2011, hosted and organised by the 
European Centre for Disease Prevention and Control 
(ECDC) [1]. The consultation brought together research-
ers, microbiologists and public health experts to dis-
cuss how public health can benefit from the recent 
scientific and technological advances in molecular 
microbiology, with special focus on the rapidly evolv-
ing next-generation sequencing technology. 
Interplay of basic and public health 
microbiological investigations: case study of 
the Escherichia coli O104:H4 outbreak in 
Germany, 2011
Angelika Fruth (Robert Koch Institute, Germany), 
Flemming Scheutz (Statens Serum Institut, Denmark) 
and Martina Bielaszewska (University of Münster, 
Germany) described how laboratories at different lev-
els contributed to the identification and detailed char-
acterisation of the Shiga toxin-producing E. coli  (STEC) 
O104:H4 strain during the 2011 outbreak in Germany 
[2-4]. The processes applied in the public health micro-
biology investigations underlined various challenges: 
obtaining relevant clinical isolates linked to outbreak 
cases at reference-laboratory level, coping with a high 
volume of tests and providing rapid feedback on anti-
genic and virulence profile information of the epidemic 
strain during the escalation phase of the outbreak.
For the first time in such a large epidemic of food-
borne bacterial disease, the whole genome sequence 
of the pathogen was determined within days of recog-
nition of the outbreak. The relative value of traditional 
microbiological methods in relation to whole genome 
sequencing (WGS) was discussed. The general opinion 
was that WGS approaches are rapidly evolving and will 
be a powerful tool in future public health emergen-
cies, especially when the infectious agent is less well 
known. However, in this particular outbreak, traditional 
methods were effective for characterising the outbreak 
strain for epidemiological investigations. It was also 
considered that other factors related to laboratory 
investigations need to be strengthened. These include 
the requirement for stool cultures for pathogen isola-
tion, access to strain collections and typing databases 
with laboratory information combined with epidemio-
logical data, better communication channels between 
laboratories and epidemiological institutes and stand-
ardisation of traditional characterisation methods 
between human and food laboratories.
Scientific and technological advances in  
molecular microbiology: what’s in it for  
public health?
Marc Achtman (Cork University, Ireland) challenged 
the existing definitions of a bacterial species and the 
ability of available laboratory methods to investigate 
population structures of different bacterial species. He 
argued for core genomic and gene polymorphism anal-
yses, as opposed to serotyping and DNA fingerprinting 
methods, for the application of phylogenetic analyses 
to support epidemiological investigations [5]. No single 
approach can yet handle the wide range of population 
structures within the group of bacteria causing human 
disease, due to considerable heterogeneity in genomic 
diversity and clonality versus recombination between 
and within species. There are a number of promising 
developments especially regarding sequencing, but for 
applications in regional public health laboratories, sci-
entific studies and technical solutions are still needed.
The use of sequencing information to investigate dis-
ease dynamics and phylogeographic mapping has a 
stronger tradition in virology. Anne-Mieke Vandamme 
(Rega Institute for Medical Research, Belgium) dem-
onstrated how integration of sequencing, epidemio-
logical and spatio-temporal data has been used to 
understand specific viral epidemics, such as the global 
migration events and selected national transmission 
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characteristics of HIV [6,7] and the rapid transmission 
of influenza A(H1N1) virus during the 2009 pandemic 
[8].
On behalf of Jacques Schrenzel (Geneva University 
Hospitals, Switzerland), Marc Struelens (ECDC) pre-
sented an overview of state-of-the-art instruments for 
genomic and proteomic analysis and discussed their 
possible future application in microbiology laborato-
ries. The main message was that novel mass spectrom-
etry technologies are being introduced into clinical 
microbiological laboratories for pathogen identifica-
tion. An open question is whether these technologies 
will achieve the simplicity combined with higher reso-
lution needed to provide subspecies strain profiling 
as well as primary diagnostic information in real time. 
Extrapolating current trends suggests that next-gen-
eration proteomic technologies will become routine in 
clinical laboratories and advanced sequencing applica-
tions in reference and research laboratory settings.
Typing as a component of epidemic 
preparedness and response support
A working group discussed experiences and identified 
challenges when adopting a validated typing method 
to operate a quality-assured system for collection and 
analysis of integrated epidemiological and microbio-
logical data at the European level. Experiences of the 
European Legionnaires’ Disease Surveillance Network 
(ELDSNET) in setting up the successful international 
system for sequence-based genotyping of Legionella 
were shared.
A network of engaged laboratories spanning all partici-
pating countries was considered key for utilising exist-
ing structures and expertise, defining disease-specific 
objectives, sampling frames and typing techniques, as 
well as collecting representative isolates.
Human pathogens encompass diverse organisms, but 
typing techniques should aim at maximum across-
species flexibility. Important health events related to 
these organisms range in scale (endemic, epidemic 
and emerging) and therefore require different sen-
tinel thresholds. Independent of disease-specific 
differences, key steps for developing effective typ-
ing networks were proposed. First, every pathogen-
specific network has to agree on a minimum set of 
metadata (place, person, time, etc.). Second, a typ-
ing approach should be agreed upon, which would 
preferably be highly versatile, and generate data with 
suitable portability, reproducibility, timeliness, trace-
ability and biological robustness. Third, a set of rules 
stipulating a suitable sampling frame should be agreed 
upon. Fourth, a web-based typing platform should be 
set up. The manner of submission, access and owner-
ship of contributors must be similar to those of other 
repositories, e.g. the National Center for Biotechnology 
Information (NCBI).
The need for regularly conducted structured molecu-
lar typing surveys to calibrate the baseline population 
structure and molecular diversity of the pathogen of 
interest was identified. Such surveys can also explore 
the role of potential sources and reservoirs of human 
pathogens using flexible sampling frames.
A clear threat to sustainability is the unpredictabil-
ity of funding in the field of European public health. 
It is therefore important to safeguard against loss of 
data and isolates by providing the necessary redun-
dancy in terms of biobanking and mirrored databases. 
Effective collection of enhanced surveillance data is 
also dependent on centralised capacity-building initia-
tives, such as regular proficiency testing, training and 
certification.
Infections pose a potential threat to all European 
Union (EU) citizens and can only be tackled by joint 
interventions. Notwithstanding ECDC’s clear mandate, 
EU Member States should provide the necessary sup-
port at national level, i.e. maintaining their countries’ 
diagnostic and reference typing services. The need for 
advanced training and capacity building was also rec-
ognised, especially in the field of bioinformatics, and 
for developing cross-disciplinary competences of pub-
lic health professionals, as provided by programmes 
such as the European Programme for Public Health 
Microbiology (EUPHEM).
Translational research for informing public  
health action
A second working group appraised if reliable predic-
tions of communicable disease pattern and impact can 
be made by combining genomic and biological infor-
mation with epidemiological and clinical data. Work at 
the Dutch National Institute for Public Health and the 
Environment (RIVM) was presented, describing efforts 
to identify risk factors and geographical origin for 
hepatitis A infection in the Netherlands via continuing 
collection of partial genome sequence information by a 
national network of clinical virology laboratories.
Although a large amount of data on pathogenicity has 
been published in the last 20 years, it was considered 
that a molecular microbiological risk assessment to 
foresee disease impact based on pathogen genotyping 
is not possible at this stage of scientific knowledge. 
However, data from major epidemiological studies of 
pathogens such as HIV, influenza virus, enterohaemor-
rhagic E.  coli and Staphylococcus aureus indicate that 
genotypic markers can help predict the probability of 
disease progression or response to therapy. Several 
participants considered that genome sequence-based 
disease predictors were better characterised in virol-
ogy than in bacteriology. It was agreed that much 
scientific work remains and EU-wide translational 
research studies should be initiated to increase the 
accuracy of these predictions. Access to comparative 
whole genome studies of large samples of bacterial 
pathogens linked to clinical and epidemiological data 
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would facilitate the detection of relevant epidemiologi-
cal–biological associations.
Free sharing of genomic data was advocated, but exist-
ing difficulties were also recognised, for example, 
ownership, confidentiality, national policies, etc. To 
stimulate scientific progress, future databases host-
ing typing and epidemiological information combined 
with innovative bioinformatic solutions should have 
adjustable access levels, depending on the users and 
purposes of using the information. Quality assurance 
and agreed nomenclature for sequence-based typing 
need to be addressed in parallel to capacity-building 
initiatives, also in bioinformatics.
Next generation technologies, such as WGS, represent 
a window of opportunity for EU-wide typing for surveil-
lance in the coming years. Intersectoral collaborations 
in research networks, combining human and veterinary 
bacteriology, virology and epidemiology with genomic 
bioinformatics, molecular biology and population 
genetics should be facilitated. Guidance and facilita-
tion by ECDC to achieve the goals of common nomen-
clature as well as intersectoral collaboration and 
capacity building would be helpful.
Optimising use of novel typing technology  
for public health
A third working group considered whether novel pro-
teomic and genomic technologies will replace existing 
methodologies in public health microbiological labora-
tories within five years. Data were presented showing 
that WGS applications are already used in the major-
ity of large outbreaks in Europe and should gradually 
replace currently used microbiological characterisa-
tion methodologies or improve them by identification 
of novel targets.
The discussion was focused on genomic methods: gaps 
and challenges in routine application of WGS in epide-
miological typing were examined. There was no con-
sensus about whether WGS will replace current typing 
techniques. Arguments against the use of WGS were 
that currently too much work is required for a small 
amount of additional useful data, the relative expense 
and that deriving phenotype from genotype remains an 
imperfect science.
A number of key hurdles for implementation of WGS 
for public health purposes were identified. Without 
either well-utilised local instrumentation or contact 
with larger sequencing institutes, many public health 
institutes are excluded from the possibility of using 
WGS routinely. The time from sampling to results is 
generally too long to use WGS for daily surveillance. 
A major unresolved question was how genome data 
should be analysed for epidemiological characterisa-
tion. Existing analysis platforms are still wanting in 
terms of user friendliness and the inability to produce 
complete and closed genomes risks fragmenting WGS 
techniques and analysis methods. Harmonisation of 
quality parameters for WGS data production is needed. 
Routine removal of genetic regions with high variation 
gave rise to concerns that too much information is left 
out of analyses – a concern for the analysis of mobile 
genetic elements that are of particular interest for pub-
lic health.
To reduce WGS data to epidemiologically useful infor-
mation is far from trivial. As it was found desirable to 
work with WGS data in a way similar to a conventional 
nomenclature of genotypes, several possibilities were 
examined, including an extended multi-locus sequence 
typing (MLST)-type classification, single nucleotide 
polymorphism-based classification or genome group-
ing into broader ‘natural’ lineages. These possible 
approaches to derive a ‘type’ are all hampered by 
considerable feasibility problems and unresolved 
ambiguities. The issue was thus left open, with the 
consideration that it was perhaps time to abandon the 
concept of ‘type’.
Some other unmet needs for public health application 
of WGS involved the central storage and curation of 
data. ECDC along with other experts could be involved 
in setting the design and accreditation standards for 
genome-based surveillance databases. ECDC could 
take part in creating a system of unique identifiers and 
link these to the European Surveillance System (TESSy). 
In addition, ECDC could support disease-specific stud-
ies on the effectiveness of WGS analysis for public 
health applications such as epidemic investigations.
Updates of ECDC and EU projects related  
to molecular surveillance and use of new  
laboratory methods
Harry Vennema (RIVM, the Netherlands) presented 
the European Commission-funded Global exchange of 
viral sequences to underpin response to health threats 
(GESTURE) project [9]. The principles agreed in this 
project are planned to be discussed for possible imple-
mentation in the World Health Organization’s upcom-
ing World Health Assembly. Dag Harmsen (University of 
Münster, Germany) gave examples of how WGS meth-
odologies have been applied in three outbreak investi-
gations: STEC in Germany (2011) [10], Klebsiella OXA-48 
in the Netherlands (2011) and Neisseria meningitidis 
in Germany (2001–2006). In two of these, WGS was 
performed in real time in parallel to traditional inves-
tigations, illustrating how sequencing technology can 
become a method of choice in these situations. Finally, 
Ivo Van Walle (ECDC) presented the ECDC plan to set up 
a generic platform for handling microbial typing data. 
The system, an extension of TESSy, will be piloted for a 
limited number of pathogens and typing methods and 
is planned to be released in spring 2012.
Conclusions
The conference clearly illustrated that recent advances 
in molecular microbial characterisation, primarily by 
WGS analysis, are opening up tremendous new sci-
entific opportunities for a better understanding of 
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the pathogenicity, evolution and spread of human 
pathogens and the epidemiology of the diseases they 
cause. This technology has considerable potential 
for improving the resolution and predictive value of 
microbial typing as applied to public health objectives 
such as disease surveillance and epidemic investiga-
tion. However, many operational hurdles need to be 
addressed in the coming years, to define the methods 
to produce, analyse, share genomic information com-
bined with epidemiological data in a meaningful way 
and build the capacity and fit-for-purpose data man-
agement platforms for public health microbiology. 
ECDC will follow up on the recommendations of the 
consultation to play the role of a facilitator, bridging 
the scientific and public health communities to jointly 
address the generic and disease-specific challenges 
identified.
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